154 related articles for article (PubMed ID: 2453081)
1. Monoclonal antibodies in gastrointestinal cancers.
Mitchell EP; Schlom J
Semin Oncol; 1988 Apr; 15(2):170-80. PubMed ID: 2453081
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of a monoclonal antibody (CA 19-9 system) in gastrointestinal disease--in comparison with CEA and IAP].
Furukawa M; Kozaka S; Kushibiki K; Ashida Y; Saito H; Yamamoto H; Furukawa T
Nihon Gan Chiryo Gakkai Shi; 1985 Feb; 20(1):25-30. PubMed ID: 3858395
[No Abstract] [Full Text] [Related]
3. [New monoclonal antibodies in the diagnosis of gastrointestinal cancers].
Heptner G; Domschke S; Domschke W
Internist (Berl); 1986 Nov; 27(11):723-8. PubMed ID: 2433247
[No Abstract] [Full Text] [Related]
4. Expression of tumor-associated polymorphic epithelial mucin and carcinoembryonic antigen in gastrointestinal carcinoid tumors. Implications for immunodiagnosis and immunotherapy.
Moyana TN; Xiang J
Cancer; 1995 Jun; 75(12):2836-43. PubMed ID: 7539715
[TBL] [Abstract][Full Text] [Related]
5. Recent progress in the immunological monitoring of carcinomas using monoclonal antibodies.
Papsidero LD
Semin Surg Oncol; 1985; 1(4):171-81. PubMed ID: 2418482
[TBL] [Abstract][Full Text] [Related]
6. [The tumor-associated antigen CA 19-9 in the differential diagnosis and course control of malignancies of the pancreas and the gastrointestinal tract].
Klapdor R; Greten H
Dtsch Med Wochenschr; 1984 Dec; 109(50):1935-9. PubMed ID: 6210188
[No Abstract] [Full Text] [Related]
7. [Tumor markers in digestive oncology: present status of the topic and prospects for the future].
Desaive C
Rev Med Liege; 1987 Nov; 42(22):881-7. PubMed ID: 2447625
[No Abstract] [Full Text] [Related]
8. Monoclonal antibodies in the diagnosis and treatment of malignant conditions.
Allum WH; Macdonald F; Fielding JW
Surg Annu; 1986; 18():41-64. PubMed ID: 2417343
[No Abstract] [Full Text] [Related]
9. [Crucial diagnostic points of tumor markers: gastrointestinal tumors].
Klöppel G
Verh Dtsch Ges Pathol; 1986; 70():159-71. PubMed ID: 2435072
[No Abstract] [Full Text] [Related]
10. Role of 131I-labelled anti-CEA/CA 19-9 monoclonal antibodies in the diagnosis and follow-up of gastrointestinal tumors.
Giordano A; Rufini V; Campioni P; Vaccaro A; Troncone L
Int J Rad Appl Instrum B; 1989; 16(2):151. PubMed ID: 2715009
[No Abstract] [Full Text] [Related]
11. [Monoclonal antibodies against tumor-associated antigens of the gastrointestinal tract. Experimental and clinical outlook].
Schmiegel WH; Kalthoff H
Dtsch Med Wochenschr; 1985 Dec; 110(50):1943-9. PubMed ID: 3908048
[No Abstract] [Full Text] [Related]
12. Immunological and biochemical characterization of the nonspecific cross-reacting antigen epitopes using twenty-three monoclonal antibodies.
Kuroki M; Arakawa F; Higuchi H; Haruno M; Wakisaka M; Matsuoka Y
Hybridoma; 1991 Oct; 10(5):557-74. PubMed ID: 1725168
[TBL] [Abstract][Full Text] [Related]
13. Potential role of tumor vaccines in GI malignancies.
Laheru DA; Jaffee EM
Oncology (Williston Park); 2000 Feb; 14(2):245-56; discussion 259-60, 265. PubMed ID: 10736811
[TBL] [Abstract][Full Text] [Related]
14. Detection of carcinoembryonic antigen and related antigens in sera of patients with gastrointestinal tumors using monoclonal antibodies in double-determinant radioimmunoassays.
Herlyn M; Blaszczyk M; Sears HF; Verrill H; Lindgren J; Colcher D; Steplewski Z; Schlom J; Koprowski H
Hybridoma; 1983; 2(3):329-39. PubMed ID: 6205981
[TBL] [Abstract][Full Text] [Related]
15. Complementary reactivities of anti-carcinoembryonic antigen and antitumor-associated glycoprotein 72 monoclonal antibodies in lung carcinomas.
Battista P; Muraro R; Mammarella S; Curia MC; Colasante A; Rosini S; Lesti G; Sacco R; French D; Frati L
Cancer Res; 1990 Nov; 50(21):6987-94. PubMed ID: 1698547
[TBL] [Abstract][Full Text] [Related]
16. [The evaluation of the efficiency in the detection of embryonal cancer and tumor-related antigens as tumor markers in gastrointestinal cancer].
Cheshenko VP
Klin Khir; 1998; (5):20-1. PubMed ID: 9787561
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of the circulating tumor-associated antigen CA 19-9 in cancers of the digestive tract].
Staab HJ; Hornung A; Anderer FA; Kieninger G
Dtsch Med Wochenschr; 1984 Jul; 109(30):1141-7. PubMed ID: 6204834
[TBL] [Abstract][Full Text] [Related]
18. Selection of a monoclonal antibody reactive with a high-molecular-weight glycoprotein circulating in the body fluid of gastrointestinal cancer patients.
Sakurai Y; Hirohashi S; Shimosato Y; Kodaira S; Abe O
Cancer Res; 1988 Jul; 48(14):4053-8. PubMed ID: 2454734
[TBL] [Abstract][Full Text] [Related]
19. CAR-3, a monoclonal antibody-defined antigen expressed on human carcinomas.
Prat M; Morra I; Bussolati G; Comoglio PM
Cancer Res; 1985 Nov; 45(11 Pt 2):5799-807. PubMed ID: 2413998
[TBL] [Abstract][Full Text] [Related]
20. Further characterization of the mucin antigen associated with malignant transformation of human colonic mucosa, detectable with the monoclonal antibody AM-3.
Hanski C; Wehnes E; Bornhoeft G; Stein H; Riecken EO
Digestion; 1990; 46 Suppl 2():461-6. PubMed ID: 1702072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
